ABEONA THERAPEUTICS INC. Quarterly Operating Income (Loss) in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Abeona Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2011 to Q2 2024.
  • Abeona Therapeutics Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$17.9M, a 69.3% decline year-over-year.
  • Abeona Therapeutics Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$56.7M, a 26.3% decline year-over-year.
  • Abeona Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$47.1M, a 7.42% increase from 2022.
  • Abeona Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$50.9M, a 43.3% increase from 2021.
  • Abeona Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$89.8M, a 10.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$56.7M -$17.9M -$7.31M -69.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$49.4M -$14.3M -$2.29M -19% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$47.1M -$13.2M -$273K -2.11% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 -$46.9M -$11.3M -$1.95M -20.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$44.9M -$10.6M -$2.55M -31.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$42.4M -$12M +$8.55M +41.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$50.9M -$12.9M +$33.7M +72.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 -$84.6M -$9.38M +$5.49M +36.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$90.1M -$8.01M +$5.71M +41.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$95.8M -$20.6M -$5.99M -41.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$89.8M -$46.7M -$32.2M -222% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$57.7M -$14.9M -$8.62M -138% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$49M -$13.7M -$1.23M -9.89% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$47.8M -$14.6M +$33.6M +69.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$81.4M -$14.5M +$1.93M +11.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$83.4M -$6.25M +$11.4M +64.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$94.8M -$12.5M +$11.5M +47.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 -$106M -$48.2M -$29.2M -153% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$77.1M -$16.4M +$1.6M +8.88% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$78.7M -$17.6M -$733K -4.33% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$78M -$24M -$11.4M -90.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$66.5M -$19.1M -$8.37M -78.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$58.2M -$18M -$9.26M -106% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$48.9M -$16.9M -$11.6M -215% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$37.4M -$12.6M -$4.12M -48.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$33.2M -$10.7M -$5.4M -102% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$27.8M -$8.75M -$2.92M -50% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$24.9M -$5.36M -$188K -3.63% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$24.7M -$8.44M -$1.73M -25.7% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$23M -$5.28M +$876K +14.2% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$23.9M -$5.83M +$421K +6.73% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 -$24.3M -$5.17M +$990K +16.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$25.3M -$6.72M -$2.59M -62.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$22.7M -$6.16M -$4.16M -208% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$18.5M -$6.25M -$5.79M -1239% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$12.8M -$6.16M -$5.53M -874% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$7.23M -$4.13M -$3.42M -487% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$3.81M -$2M -$674K -50.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$3.13M -$467K +$217K +31.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$3.35M -$633K +$63K +9.05% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$3.41M -$703K +$1.22M +63.4% Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-08-14
Q1 2014 -$4.63M -$1.33M -$825K -164% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$3.8M -$684K +$535K +43.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$4.34M -$696K +$260K +27.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$4.6M -$1.92M -$469K -32.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$4.13M -$503K +$186K +27% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$4.32M -$1.22M +$471K +27.9% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-26
Q3 2012 -$4.79M -$956K +$828K +46.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$5.62M -$1.45M +$801K +35.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$6.42M -$689K +$1.46M +67.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$7.88M -$1.69M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-20
Q3 2011 -$1.78M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$2.25M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$2.15M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.